Anika Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil prices, producer inflation ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Anika Therapeutics (ANIK) Tops Q3 EPS by 25c
October 24, 2019 4:36 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.64, $0.25 better than the analyst estimate of $0.39. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $27.01 million.
Anika delivered double-digit revenue and earnings growth in the third quarter on the strength of growing global demand, Anikas expanding commercial platform, and... More
